Health & Food

Focal Biosciences - a new vision for cell reprogramming

An ETH spinoff, Focal Biosciences develops a scalable cellular reprogramming discovery platform for interventions that restore a functional cell state in the physiological context of aging and age-related disease using novel epigenetic signatures. >website

ETH Industry Day 2021
Powered by  GDPR Cookie Compliance
Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.